Literature DB >> 11384793

The childhood asthma prevention study (CAPS): design and research protocol of a randomized trial for the primary prevention of asthma.

S Mihrshahi1, J K Peat, K Webb, E R Tovey, G B Marks, C M Mellis, S R Leeder.   

Abstract

The Childhood Asthma Prevention Study is a randomized controlled trial to measure whether the incidence of atopy and asthma can be reduced by house dust mite allergen reduction, a diet supplemented with omega-3 fatty acids, or a combination of both interventions. Six hundred and sixteen pregnant women whose unborn children were at high risk of developing asthma because of a family history were randomized prenatally. Study groups are as follows: Group A (placebo diet intervention, no house dust mite reduction), Group B (placebo diet intervention, active house dust mite reduction), Group C (active diet intervention, no house dust mite reduction), and Group D (active diet intervention, active house dust mite reduction). The house dust mite reduction intervention comprises use of physical and chemical methods to reduce allergen contact. The dietary intervention comprises use of a daily oil supplement from 6 months or at onset of bottle-feeding, and use of margarine and cooking oils based on sunflower or canola oils to increase omega-3 dietary intake. Data is collected quarterly until the infant is 1 year old and then half yearly until age 5 years. Questionnaires are used to collect respiratory illness history and information about diet and home environment. Dust is collected from the child's bed and bedroom and playroom floors. Blinded assessments are conducted at 18 months, 3 years, and 5 years. Skin prick tests to common allergens, blood tests, and detailed illness, medication use, and vaccination histories are collected. Primary outcomes will be the development of allergic sensitization and the presence and severity of asthma. This study is designed to measure the effectiveness of allergen reduction and dietary supplementation, both separately and in combination, for the primary prevention of atopy and asthma. The results of this study may have important implications for public health policies to reduce the incidence of childhood asthma. Control Clin Trials 2001;22:333-354

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11384793     DOI: 10.1016/s0197-2456(01)00112-x

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  19 in total

1.  High-throughput analysis of plasma fatty acid methyl esters employing robotic transesterification and fast gas chromatography.

Authors:  M Athar Masood; Norman Salem
Journal:  Lipids       Date:  2007-12-15       Impact factor: 1.880

2.  Cost-effectiveness of primary prevention of paediatric asthma: a decision-analytic model.

Authors:  G Feljandro P Ramos; Antoinette D I van Asselt; Sandra Kuiper; Johan L Severens; Tanja Maas; Edward Dompeling; J André Knottnerus; Onno C P van Schayck
Journal:  Eur J Health Econ       Date:  2013-10-06

3.  Automated high-throughput fatty acid analysis of umbilical cord serum and application to an epidemiological study.

Authors:  Yu Hong Lin; Norman Salem; Ellen M Wells; Weiyin Zhou; James D Loewke; James A Brown; William E M Lands; Lynn R Goldman; Joseph R Hibbeln
Journal:  Lipids       Date:  2012-03-21       Impact factor: 1.880

4.  The Vitamin D Antenatal Asthma Reduction Trial (VDAART): rationale, design, and methods of a randomized, controlled trial of vitamin D supplementation in pregnancy for the primary prevention of asthma and allergies in children.

Authors:  Augusto A Litonjua; Nancy E Lange; Vincent J Carey; Stacey Brown; Nancy Laranjo; Benjamin J Harshfield; George T O'Connor; Megan Sandel; Robert C Strunk; Leonard B Bacharier; Robert S Zeiger; Michael Schatz; Bruce W Hollis; Scott T Weiss
Journal:  Contemp Clin Trials       Date:  2014-03-12       Impact factor: 2.226

5.  Central blood pressure in children and adolescents: non-invasive development and testing of novel transfer functions.

Authors:  T Y Cai; A Qasem; J G Ayer; M Butlin; S O'Meagher; C Melki; G B Marks; A Avolio; D S Celermajer; M R Skilton
Journal:  J Hum Hypertens       Date:  2017-08-24       Impact factor: 3.012

Review 6.  Allergen avoidance as primary prevention: con.

Authors:  Susanne Lau
Journal:  Clin Rev Allergy Immunol       Date:  2005-02       Impact factor: 8.667

Review 7.  Atopy risk in infants and children in relation to early exposure to fish, oily fish, or long-chain omega-3 fatty acids: a systematic review.

Authors:  Lefkothea-Stella Kremmyda; Maria Vlachava; Paul S Noakes; Norma D Diaper; Elizabeth A Miles; Philip C Calder
Journal:  Clin Rev Allergy Immunol       Date:  2011-08       Impact factor: 8.667

8.  Omega-3 supplementation during the first 5 years of life and later academic performance: a randomised controlled trial.

Authors:  B K Brew; B G Toelle; K L Webb; C Almqvist; G B Marks
Journal:  Eur J Clin Nutr       Date:  2014-08-13       Impact factor: 4.016

Review 9.  Prevention of allergic sensitization by environmental control.

Authors:  Angela Simpson; Adnan Custovic
Journal:  Curr Allergy Asthma Rep       Date:  2009-09       Impact factor: 4.806

Review 10.  Wheeze as an adverse event in pediatric vaccine and drug randomized controlled trials: A systematic review.

Authors:  Diana Marangu; Stephanie Kovacs; Judd Walson; Jan Bonhoeffer; Justin R Ortiz; Grace John-Stewart; David J Horne
Journal:  Vaccine       Date:  2015-08-28       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.